TY - JOUR
T1 - The state of migraine
T2 - An update on current and emerging treatments
AU - Ray, Jason C.
AU - Macindoe, Caroline
AU - Ginevra, Michael
AU - Hutton, Elspeth J.
N1 - Publisher Copyright:
© 2021. The Royal Australian College of General Practitioners. All Rights Reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Background Migraine is a common neurological disorder, affecting one in seven people, and is the second leading cause of disability worldwide. Objective The aim of this article is to summarise the diagnosis, pathophysiology and treatment of migraine. Discussion Key to limiting the disability of migraine and progression to chronic migraine is addressing modifiable risk factors, including implementing effective preventive treatment and avoiding overuse of acute treatment. In this article, the authors review strategies for effective acute and preventive treatment of migraine and introduce the new treatments of migraine targeting calcitonin gene-related peptide signalling.
AB - Background Migraine is a common neurological disorder, affecting one in seven people, and is the second leading cause of disability worldwide. Objective The aim of this article is to summarise the diagnosis, pathophysiology and treatment of migraine. Discussion Key to limiting the disability of migraine and progression to chronic migraine is addressing modifiable risk factors, including implementing effective preventive treatment and avoiding overuse of acute treatment. In this article, the authors review strategies for effective acute and preventive treatment of migraine and introduce the new treatments of migraine targeting calcitonin gene-related peptide signalling.
UR - http://www.scopus.com/inward/record.url?scp=85122233943&partnerID=8YFLogxK
U2 - 10.31128/AJGP-01-21-5807
DO - 10.31128/AJGP-01-21-5807
M3 - Article
C2 - 34845471
AN - SCOPUS:85122233943
SN - 2208-794X
VL - 50
SP - 915
EP - 921
JO - Australian Journal of General Practice
JF - Australian Journal of General Practice
IS - 12
ER -